A Transformer-Based Deep Learning Model for predicting Early Recurrence in Hepatocellular Carcinoma After Hepatectomy Using Intravoxel Incoherent Motion Images
Related Experiment Video
Updated: Mar 27, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Hongxiang Li1, Zehong Qiu2, Jing Zhang1
1Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Background:
This study aimed to develop and validate a transformer framework-based deep learning (DL) network using intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) to predict early recurrence in hepatocellular carcinoma (HCC).
Materials And Methods:
This retrospective study included 122 patients with HCC who underwent magnetic resonance imaging examination, including an IVIM-DWI sequence with nine b-values, before resection. These were divided into training (n=85) and test (n=37) sets. A vision transformer (ViT) framework-based DL was developed to predict early recurrence in HCC. Deep features were extracted from nine b-value DWI images and IVIM parametric maps and fused to construct the fused DL (ViT-fDL) prediction model. A clinical model was constructed using multivariate logistic regression analysis. A combined model was constructed using deep features from the ViT-fDL model and clinical independent features. The performances of the models were evaluated by discrimination, calibration, and clinical applicability.
Results:
Among 122 patients (108 males,14 females; mean age, 51.0 ± 11.9 years), 49 (40.1%) experienced early recurrence. The respective areas under the curve for the training and test sets were 0.755 (95% Confidence interval (CI), 0.650-0.842) and 0.764 (95% CI, 0.596-0.887) using the clinical model, 0.968 (95% CI, 0.905-0.994) and 0.815 (95% CI, 0.653-0.923) using the ViT-fDL model, and 0.991 (95% CI, 0.940-1.000) and 0.821 (95% CI, 0.660-0.927) using the combined model.
Conclusion:
The ViT-fDL model based on IVIM can be useful for preoperative prediction early recurrence in HCC. The combined model was a more effective and precise prediction tool than other models, promising to guide individualized postoperative monitoring.
More Related Videos
08:15A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024